Pancreatic Cancer

A role for immunotherapy: preventing macrophage anergy in the tumour environment
Androulla Elia, James Mapes, Thomas Knorpp, Manfred Schmolz, Eric Garcia, Thorsten Hagemann, Laura Rosa Brunet

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P185; DOI: 10.1186/2051-1426-1-S1-P185
Genetically engineered murine pancreatic cancer models approximate immunophenotypic properties of human patients
Thomas A Mace, Jason Pitaressi, Reena Shakya, Wendy Frankel, Tim Eubank, Tanios Bekaii-Saab, Mark Bloomston, Mitch Phelps, Thomas Ludwig, Michael Ostrowski, Gregory B Lesinski

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P163; DOI: 10.1186/2051-1426-1-S1-P163
Development of mutome-specific personalized vaccines for pancreatic cancer
Eric Lutz, Heather Kinkead, Allison Yager, Todd Armstrong, Peter Lauer, Dirk Brockstedt, Thomas Dubensky, Elizabeth Jaffee

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P224; DOI: 10.1186/2051-1426-1-S1-P224
S81. Proffered paper: A new PD1-CD28 chimeric receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapy
S Grassmann, P Peters, Y Zeng, J Schmollinger, S Endres, S Kobold

Journal for ImmunoTherapy of Cancer Mar 2014, 2 (Suppl 2) I19; DOI: 10.1186/2051-1426-2-S2-I19

Main menu